Bronchial artery embolization in management of hemoptysis: Safety and efficacy

Elhusseiny, Mahmoud; Abdelhafez, Sayed A; Amer, Talal; Eid, Raed Elmetwally Ali; Suliman, Lusy Abd-ELmaboud

doi:10.1016/j.ejcdt.2017.08.008

Cited by 4 publications

(8 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In our study, the origin of the bronchial arteries was observed in (27.8%) of patients from the right intercosto-bronchial trunk, of direct origin from the left BA (25%) and right BA (19%), from the left IBT (17%) whilst common trunk of both BAs was noted in( 3%) which was in agreement with ElHusseiny et al (22) . Non bronchial source of bleeding was noted in nearly 8% of patients distributed between internal mammary artery, phrenic and subcalvian arteries.…”

Section: Regarding the Source Of Bleedingsupporting

confidence: 92%

“…On the contrary, Agamy et al (2) reported fever as the most common subacute complication post BAE in (29%) of their patients, followed by chest pain (5%) that were self-limiting with conservative management. Iatrogenic bronchial dissection in 3 patients was also noted among the complications reported by Elhusseiny et al (22) fortunately with no grave squeal. Moreover, hemoptysis in those patients stopped with no necessity for further intervention or bronchoscopic rescue maneuvers.…”

Section: Elhusseiny Et Almentioning

confidence: 65%

“…Various neurologic complications were stated by Elhusseiny et al (22) encompassing transient low back pain which was relieved by analgesics and right lower limb numbness and tingling attributable to femoral neuralgia during arterial puncture that persisted for about one week, yet were well-controlled thereafter via analgesics and vitamin B6 & B12 injections.…”

Section: Elhusseiny Et Almentioning

confidence: 99%

“…Elhusseiny et al (22) reported femoral puncture site pain in (56%) of patients, followed by chest pain (32%), fever & nausea (16%). On the contrary, Agamy et al (2) reported fever as the most common subacute complication post BAE in (29%) of their patients, followed by chest pain (5%) that were self-limiting with conservative management.…”

Section: Elhusseiny Et Almentioning

confidence: 99%

“…In our study no deaths were noted. (22) reported one death during the course of his study in patient with right lobar mycetoma with recurrent massive hemoptysis for which BAE was successfully done, but death was attributed to rupture of dissecting abdominal aortic aneurysm.…”

Section: Regarding Complication Of Baementioning

confidence: 99%

See 4 more Smart Citations

Bronchial Artery Embolization as a Therapeutic Strategy for Management of Massive Hemoptysis

Abdurrahman

Ibrahim

Mohammad

et al. 2021

Ain Shams Medical Journal

View full text Add to dashboard Cite

Background: Massive hemoptysis is an emergent and lifethreatening condition with a high mortality rate. Bronchoscopy and MDCT scanning show significant contributing roles in delineating the etiology and the source of hemoptysis prior to bronchial artery arteriography. Aim of the work:To validate the role of the trans-catheter bronchial artery embolization in management of massive hemoptysis.Patients and Methods: Our study is a prospective cohort study that was held during the period between April 2017 and April 2019. The study included 20 patients who presented with massive hemoptysis refractory to supportive treatment measures with nonidentifiable source of bleeding on fiber-optic bronchoscope. Patients were referred from chest department to angio unit.Results: Our findings are in accordance with the current literature supporting bronchial artery embolization as a safe and long-term non-invasive effective method of treatment for massive hemoptysis with a high initial rate of success. BAE may help to avoid surgery in patients who are not good surgical candidates. If hemoptysis recur in these patients, embolization can be safely performed with good response rate. If surgery is indicated, BAE can stabilize the patient prior to surgery. Conclusion:Advancements in angiographic equipment and technique continue to improve success rates, and with careful technique, it can be performed safely and with minimal risk. Embolization distal to the spinal artery may significantly decrease the number of complications and may allow a more thorough embolization.

show abstract

Section: Regarding the Source Of Bleedingsupporting

confidence: 92%

Section: Elhusseiny Et Almentioning

confidence: 65%

Section: Elhusseiny Et Almentioning

confidence: 99%

Section: Elhusseiny Et Almentioning

confidence: 99%

Section: Regarding Complication Of Baementioning

confidence: 99%

See 3 more Smart Citations

Bronchial Artery Embolization as a Therapeutic Strategy for Management of Massive Hemoptysis

Abdurrahman

Ibrahim

Mohammad

et al. 2021

Ain Shams Medical Journal

View full text Add to dashboard Cite

show abstract

Application of the 5F JL4 Catheter in Bronchial Artery Embolization With the Opening in the Inferior Wall of the Aortic Arch

Dong

Niu

2023

Vasc Endovascular Surg

View full text Add to dashboard Cite

Background We investigated the efficacy and safety of bronchial artery embolization (BAE) using a 5F JL4 catheter in patients with hemoptysis and a bronchial artery opening in the inferior wall of the aortic arch. Methods This was a single-center retrospective study. Seventeen patients underwent BAE using 5F JL4. We then evaluated technical success (TS), clinical success (CS), incidence of complications, and hemoptysis recurrence rate (RR). Results The TS rate of microcatheter superselective catheterization and CS rate after surgery were 100%, and the incidence of severe complications and postoperative RR were 17.6%. Conclusions Bronchial artery embolization for hemoptysis with a BA opening in the inferior wall of the aortic arch using the 5F JL4 catheter could be a safe method. The short- and medium-term results were excellent.

show abstract

A retrospective study on the management of massive hemoptysis by bronchial artery embolization: risk factors associated with recurrence of hemoptysis

Ding

Zhai

et al. 2023

BMC Pulm Med

View full text Add to dashboard Cite

Background Massive hemoptysis is a life-threatening condition that requires immediate treatment. This study aimed to retrospectively analyze the outcome of bronchial artery embolization (BAE) for massive hemoptysis, as well as potential factors that may contribute to the recurrence of hemoptysis after BAE. Methods A total of 105 patients with massive hemoptysis treated with BAE were analyzed. Results The immediate control rate of bleeding was 84.8% (67/79); however, during the 36-month follow-up, 45.3% (29 out of 64) of the patients had recurrent hemoptysis after BAE. Comorbidities, pituitary hormone treatment, the angiographic appearance of artery dilation and hypertrophy, and the materials used for BAE were significantly correlated with the success rate of the BAE, while lack of pituitary hormone treatment and existence of arterio-arterial or arteriovenous fistula were risk factors for the recurrence of hemoptysis after BAE. Only a small proportion of patients (9/105, 8.6%) had mild complications after BAE treatment. Conclusion Findings suggest that BAE continues to be an effective treatment for massive hemoptysis in emergency settings. Moreover, the treatment of underlying pulmonary diseases and comorbidities is important to increase BAE’s success rate of BAE and decrease the risk of recurrent hemoptysis after BAE.

show abstract

Bronchial artery embolization in management of hemoptysis: Safety and efficacy

Cited by 4 publications

References 13 publications

Bronchial Artery Embolization as a Therapeutic Strategy for Management of Massive Hemoptysis

Bronchial Artery Embolization as a Therapeutic Strategy for Management of Massive Hemoptysis

Application of the 5F JL4 Catheter in Bronchial Artery Embolization With the Opening in the Inferior Wall of the Aortic Arch

A retrospective study on the management of massive hemoptysis by bronchial artery embolization: risk factors associated with recurrence of hemoptysis

Contact Info

Product

Resources

About